Percorsi clinici
Pubertà precoce da causa organica
Precocious puberty due to organic causes
Mariarosaria Cozzolino, Andrea Zucchini, Federico Marchetti
UOC di Pediatria e Neonatologia, Ospedale di Ravenna, AUSL della Romagna
Aprile 2019 - pagg. 243 -246
Abstract
The paper describes a case of a child with rapidly progressive central puberty (PPC) secondary
to hypothalamic hamartoma. Hypothalamic hamartoma is a congenital malformation
diagnosed with MRI. It may be associated with PPC, gelastic seizures and moderate
mental retardation. Precocious puberty is defined by the appearance of pubertycompatible
symptoms at an age of less than 2.5 SD from the mean, before the age of
eight in girls and nine in boys. The prevalence is 10 times higher in girls. The organic
forms recognise as a mechanism the premature activation of gonadotropin-releasing hormone
secretion, secondary to tumours or hypothalamic lesions. Idiopathic forms are
more common in females and occur in the 6-8-age group. In males the organic forms
cover about 50% of the possibilities and therefore there is always the indication to perform
an MRI. Often no therapy is needed especially when the onset is in the 6-8-age
range in females, and around the age of 9 in males. In cases with progressive PPC,
there may be unfavourable psychosocial problems and short stature, therefore the indication
to therapy will have to be discussed with patients’ families case by case.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Cianfarani S. La pubertà precoce. Medico
e Bambino 2004;23(8):485-91.
2. Gruppo di Studio SIEDP - Fisiopatologia
dei processi di accrescimento e della pubertà
PDTA. Percorso diagnostico terapeutico assistenziale:
la pubertà precoce. SIEDP-2018, 30
maggio 2017.
3. Kletter GB, Klein KO, Wong YY. A pediatrician’s
guide to central precocious puberty.
Clin Pediatr 2015;54(5):414-24.
4. Mogensen SS, Aksglaede L, Mouritsen A,
et al. Diagnostic work-up of 449 consecutive
girls who were referred to be evaluated for
precocious puberty. J Clin Endocrinol Metabol
2011;96(5):1393-401.
5. Carel JC, Léger J. Clinical practice. Precocious
puberty. N Engl J Med 2008;358(22):
2366-77.
6. Carrozzi M, Skabar A, Marras CE. Amartoma
ipotalamico e crisi gelastiche. Medico e
Bambino pagine elettroniche 2019;22(3):83-5.
7. Wang B, Ma J. The diagnosis and management
of hypothalamic hamartomas in children.
Chinese Neurosurgical Journal
2016;2:29.
8. Pierobon C, Driul D, Crichiutti G. Le crisi
gelastiche. Medico e Bambino pagine elettroniche
2016;19(3).
9. Harrison VS, Oatman O, Kerrigan JF. Hypothalamic
hamartoma with epilepsy: review
of endocrine comorbidity. Epilepsia 2017;
58(Suppl 2):50-9.
10. Nguyen D, Singh S, Zaatreh M, et al. Hypothalamic
hamartomas: seven cases and review
of the literature. Epilepsy Behav 2003;4
(3):246-58.
11. Li CD, Luo SQ, Tang J, et al. Classification
of hypothalamic hamartoma and prognostic
factors for surgical outcome. Acta Neurol
Scand 2014;130(1):18-26.
12. Nagaki S, Otsuka E, Miwa K. et al. Case
Report. Two cases of precocious puberty associated
with hypothalamic hamartoma. Clin
Pediatr Endocrinol 2010;19 (2):31-7.
13. Chan YM, Fenoglio-Simeone KA, Paraschos
S. et al. Central precocious puberty
due to hypothalamic hamartomas correlates
with anatomic features but not with expression
of GnRH, TGFalfa, or KISS1. Horm Res
Paediatr 2010;73(5):312-9.
14. Rousseau-Nepton I, Kaduri S, Garfield N,
Krishnamoorthy P. Hypothalamic hamartoma
associated with central precocious puberty
and growth hormone deficiency. J Pediatr
Endocrinol Metab 2014; 27(1-2):117-21.
15. Martin DD, Seeger U, Ranke M, Grodd
W. MR imaging and spectroscopy of a tuber
cinereum hamartoma in a patient with
growth hormone deficiency and hypogonadotropic
hypogonadism. AJNR Am J Neuroradiol
2003;24(6):1177-80.
16. Voyadzis JM, Guttman-Bauman I, Santi
M, Cogen P. Hypothalamic hamartoma secreting
corticotrophin-releasing hormone. J
Neurosurg 2004;100(2 Suppl Pediatrics):212-
6.
17. Chiarelli F, Conte E. Uso degli analoghi
del GnRH nei bambini. Medico e Bambino
2010;29(7):435-45.
18. Guerrini R, Giordano F, Genitori L. Barba
C. Epilessia grave nel bambino: il ruolo del
trattamento chirurgico. Medico e Bambino
2012;31(4):240-3.
Corrispondenza: drmariarosariacozzolino@gmail.com